Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxandrolone, growth hormone, and low-dose estrogen study in girls with Turner syndrome
NL-OMON29682Active, not recruiting
- Sponsor
- Nederlandse Groeistichting
- Start
- Dec 1991
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxandrolone, somatropin, ethinyl estradiol and estradiol in Turner syndrome (TS) (3 arms), sponsored by Nederlandse Groeistichting. Primary endpoints: Clinical, auxological and biochemical parameters, Changes in characteristics of the voice and 1 more. Started Dec 1991; status: active, not recruiting.
02
Drugs
oxandrolonesomatropinethinyl estradiolestradiol
03
Conditions
Turner syndrome (TS)
Beyond the preview
Go deeper on NL-OMON29682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29682.